Skip to main content

Prader-Willi Syndrome clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • Open-Label Extension Study of Diazoxide Choline in Patients With Prader-Willi Syndrome

    Sorry, in progress, not accepting new patients

    The purpose of this is study is to evaluate the long term safety of DCCR (diazoxide choline controlled release tablets) in children and adults with Prader-Willi syndrome. After completion of 1 year in this study, subjects will have the option to continue treatment for up to 2 additional years.

    Orange, California and other locations